Valeria Famiglini

Rome, 00185, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

New 6- and 7-heterocyclyl-1H-indole derivatives as potent tubulin assembly and cancer cell growth inhibitors.

New 6- and 7-heterocyclyl-1H-indole derivatives as potent tubulin assembly and cancer cell growth inhibitors.

Journal: European journal of medicinal chemistry

Published: February 20, 2018

Indolylarylsulfones, a fascinating story of highly potent human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors.

Indolylarylsulfones, a fascinating story of highly potent human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors.

Journal: Antiviral chemistry & chemotherapy

Published: February 09, 2018

β-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy.

β-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy.

Journal: Oncogene

Published: September 18, 2017

Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities.

Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: August 05, 2017

Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 Agents.

Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 Agents.

Journal: Journal of medicinal chemistry

Published: June 20, 2017

N-Pyrrylarylsulfones with High Therapeutic Potential.

N-Pyrrylarylsulfones with High Therapeutic Potential.

Journal: Molecules (Basel, Switzerland)

Published: February 12, 2017

Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors.

Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: January 18, 2017

3-Aroyl-1,4-diarylpyrroles Inhibit Chronic Myeloid Leukemia Cell Growth through an Interaction with Tubulin.

3-Aroyl-1,4-diarylpyrroles Inhibit Chronic Myeloid Leukemia Cell Growth through an Interaction with Tubulin.

Journal: ACS medicinal chemistry letters

Published: January 13, 2017

New Inhibitors of Indoleamine 2,3-Dioxygenase 1: Molecular Modeling Studies, Synthesis, and Biological Evaluation.

New Inhibitors of Indoleamine 2,3-Dioxygenase 1: Molecular Modeling Studies, Synthesis, and Biological Evaluation.

Journal: Journal of medicinal chemistry

Published: October 04, 2016

Mitotic cell death induction by targeting the mitotic spindle with tubulin-inhibitory indole derivative molecules.

Mitotic cell death induction by targeting the mitotic spindle with tubulin-inhibitory indole derivative molecules.

Journal: Oncotarget

Published: April 13, 2016

Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors.

Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors.

Journal: Molecules (Basel, Switzerland)

Published: January 11, 2016

Discovery of 1,1'-Biphenyl-4-sulfonamides as a New Class of Potent and Selective Carbonic Anhydrase XIV Inhibitors.

Discovery of 1,1'-Biphenyl-4-sulfonamides as a New Class of Potent and Selective Carbonic Anhydrase XIV Inhibitors.

Journal: Journal of medicinal chemistry

Published: October 27, 2015

Showing 1-12 of 23

Last Updated: 09/26/2026